More on GDTC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CytoMed Therapeutics (NQ:GDTC)
Delayed: 1.05 +0.01 (0.96%)
Prev. Close $1.04  
Open$1.01 
52 Wk High$ 
52 Wk Low$ 
Day High$1.05 
Day Low$1.01 
P/E N/A  
EPS$ 
Volume2,280 

Friends, Peers and Foes (?): TCBPY (more...)

Feb 12, 2026 09:05 AM Form 144 CytoMed Therapeutics Filed by: mDR Ltd
Jan 28, 2026 11:41 AM Form 6-K CytoMed Therapeutics For: Jan 28
Jan 28, 2026 10:00 AM CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
Jan 13, 2026 08:05 AM CytoMed seeks shareholder input on cell therapy access proposal
Jan 13, 2026 08:01 AM Form 6-K CytoMed Therapeutics For: Jan 13
Jan 13, 2026 08:00 AM CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
Dec 8, 2025 08:03 AM CytoMed partners with Malaysia hospital for cancer cell therapy trial
Dec 8, 2025 08:00 AM Form 6-K CytoMed Therapeutics For: Dec 08
Dec 8, 2025 08:00 AM CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogene
Nov 18, 2025 08:00 AM CytoMed completes acquisition of T cell technology for China market
View All Articles

Entities mentioned with GDTC

View All Entities